What do we know about atm protein expression in breast tissue?;Que savons-nous de l'expression de la protéine atm dans le tissu mammaire?

Bulletin du Cancer

Volumn 88, Issue 7, 2001, Pages 671-675

  Angele S ^a   Teniere P ^a   Hall, J ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Ataxia telangiectasia; Breast; Protein

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; PROTEIN P53; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ATAXIA TELANGIECTASIA; BREAST; BREAST CANCER; BREAST CARCINOGENESIS; CANCER SUSCEPTIBILITY; DNA DAMAGE; FEMALE; GENE MUTATION; HUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; BREAST TUMOR; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; GENETICS; METABOLISM; PAGET NIPPLE DISEASE; TUMOR SUPPRESSOR GENE;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL CYCLE PROTEINS; DISEASE SUSCEPTIBILITY; DNA-BINDING PROTEINS; FEMALE; GENES, P53; HUMANS; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0034741660     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Pathologie et pronostic
2. Cancer risks in A-T heterozygotes
3. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia
4. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: Haplo-type study in French AT families
5. Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations
6. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma and breast cancer
7. The ATM gene and breast cancer: Is it really a risk factor?
8. ATM: The protein encoded by the gene mutated in the radiosensitive syndrome ataxia telangiectasia
9. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage
10. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products
11. Requirement of ATM-dependent phosphorylation of Brcal in the DNA damage response to double-strand breaks
12. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response
13. Upregulation of ATM in sclerosing adenosis of the breast
14. ATM protein synthesis patterns in sporadic breast cancer
15. Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas
16. Enhanced phosphorylation of p53 by ATM in response to DNA damage
17. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms
18. ATM binds to β-adaptin in cytoplasmic vesicles
19. Localization of a portion of extranuclear ATM to perioxisomes
20. Expression of the ATM gene is significantly reduced in sporadic breast carcinomas
21. Lack of defective expression of the ATM gene in sporadic breast cancer tissues and cell lines
22. High incidence of cancer in a family segregating a mutation of the ATM gene: Possible role of ATM heterozygosity in cancer
23. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer
24. Downregulation of BRCA1 in human sporadic breast cancer: Analysis of DNA methylation patterns of the putative promoter region
25. Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene
26. Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers
27. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: Correlation with disease characteristics
28. p53 and human cancer: The first ten thousand mutations
29. The role of ATM in DNA damage responses and cancer
30. DNA damage-induced activation of p53 by the checkpoint kinase Chk2
31. Functions of the MDM2 oncoprotein
32. Activation de p53 par les kinases de la famille PI-3K après cassures double brin de l'ADN
33. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
34. G2/M-phase arrest and release in ataxia telangiectasia and normal cells after exposure to ionizing radiation
35. Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas